NovaBay Pharmaceuticals, Inc. R&D Expenses

R&D Expenses of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including R&D Expenses growth rates and interactive chart. Research and development (R&D) expenses are associated with the research and development of a company's goods or services. A company generally incurs R&D expenses in the process of finding and creating new products or services. It is an operating expense and can be deducted from a company's income taxes.


Highlights and Quick Summary

  • R&D Expenses for the quarter ending June 30, 2022 was $40 Thousand (a 42.86% increase compared to previous quarter)
  • Year-over-year quarterly R&D Expenses increased by 300.0%
  • Annual R&D Expenses for 2021 was $44 Thousand (a -84.56% decrease from previous year)
  • Annual R&D Expenses for 2020 was $285 Thousand (a 54.89% increase from previous year)
  • Annual R&D Expenses for 2019 was $184 Thousand (a -28.96% decrease from previous year)
  • Twelve month R&D Expenses ending June 30, 2022 was $86 Thousand (a 28.36% increase compared to previous quarter)
  • Twelve month trailing R&D Expenses increased by 19.44% year-over-year
Trailing R&D Expenses for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$86 Thousand $67 Thousand $44 Thousand $72 Thousand
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical R&D Expenses of NovaBay Pharmaceuticals, Inc.

Most recent R&D Expensesof NBY including historical data for past 10 years.

Interactive Chart of R&D Expenses of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. R&D Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.04 $0.03
2021 $0.01 $0.01 $0.02 $0.01 $0.04
2020 $0.04 $0.13 $0.12 $0.01 $0.29
2019 $0.02 $0.05 $0.03 $0.09 $0.18
2018 $0.11 $0.05 $0.06 $0.05 $0.26
2017 $0.15 $0.13 $0.07 $0.06 $0.41
2016 $0.16 $0.0 $0.28 $0.93 $1.37
2015 $1.23 $1.56 $1.36 $1.58 $5.73
2014 $2.39 $2.31 $2.24 $2.55 $9.48
2013 $4.09 $2.51 $2.94 $2.93 $12.46
2012 $2.12 $2.51 $2.38 $2.26 $9.28
2011 $2.2 $2.02 $9.91

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology